시장보고서
상품코드
1684379

포유류 세포 발효 기술 시장 : 종류별, 용도별, 최종 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2025-2032년)

Mammalian Cell Fermentation Technology Market, By Type, By Application, By End-use, By Country, and By Region -Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 311 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

포유류 세포 발효 기술 시장 규모는 2024년 507억 8,943만 달러로 2025년부터 2032년까지 CAGR 8.99%로 성장할 것으로 예상됩니다.

포유류 세포 발효 기술 시장 역학

생물학적 제제 및 바이오시밀러에 대한 수요 증가가 시장 성장을 촉진합니다.

포유류 세포 발효 기술 산업은 바이오시밀러 및 생물학적 제제에 대한 수요 증가로 인해 현저한 상승세를 보이고 있습니다. 이러한 치료제는 감염, 암, 자가면역질환 등 다양한 증상을 관리하는 데 중요한 역할을 합니다. 또한, 제약회사들이 새로운 생물학적 제제 개발을 위해 많은 투자를 하고 있기 때문에 포유류 세포 발효 기술은 계속 확대되고 있습니다. 그러나 이 기술의 보급을 억제하는 중요한 요인은 제조 공정과 관련된 높은 비용입니다. 또한 암, 당뇨병, 심장병과 같은 만성질환의 증가는 포유류 세포 발효 기술 시장의 성장을 가져왔습니다. 많은 질병이 장기적인 치료가 필요하고, 많은 경우 생물학적 제제를 사용하기 때문에 포유류 세포 발효 기술에 대한 수요가 계속되고 있습니다. 그 결과, 포유류 세포 발효 기술 시장은 만성질환의 증가와 함께 바이오시밀러 및 생물학적 제제에 대한 지속적인 수요로 인해 향후 몇 년 동안 성장할 것으로 예상됩니다.

포유류 세포 발효 기술 시장 : 주요 인사이트

당사의 연구 분석가들이 공유한 분석에 따르면, 세계 시장은 예측 기간(2025-2032년) 동안 매년 약 8.99%의 CAGR로 성장할 것으로 추정됩니다.

유형별로는 중국 햄스터 난소(CHO) 세포 발효가 2024년 가장 큰 시장 점유율을 보일 것으로 예측되었습니다.

용도별로 보면 2024년 단클론항체가 주요 용도입니다.

최종 용도별로는 2024년 CMO와 CDMO가 주요 최종 용도였습니다.

지역별로는 북미가 2024년 주요 수익원입니다.

포유류 세포 발효 기술 시장 : 세분화 분석

세계 포유류 세포 발효 기술 시장은 유형, 용도, 최종 용도 및 지역에 따라 세분화됩니다.

시장은 유형별로 아기 햄스터 신장(BHK) 세포 발효, 중국 햄스터 난소(CHO) 세포 발효, 인간 배아 신장(HEK) 세포 발효, 마우스 골수종 세포 발효, 기타로 구분됩니다. 중국 햄스터 난소(CHO) 세포 발효 분야가 시장을 주도할 것으로 예상되며, CHO 세포는 복잡한 치료용 단백질을 효율적으로 생산할 수 있다는 점에서 큰 주목을 받고 있습니다. 또한, 배양 배지 및 배양 조건의 최적화, 세포주 개발 강화를 위한 유전공학 기술의 발전, 강력한 규제 환경 등 다양한 요인이 수요 증가에 기여하고 있습니다.

시장은 용도별로 효소, 호르몬, 단클론항체, 재조합 단백질, 백신, 백신, 기타의 6가지 카테고리로 분류됩니다. 단클론항체 분야는 진단 및 치료 분야에서 항체가 차지하는 중요한 역할로 인해 높은 채택률로 인해 견고한 생산 방법에 대한 수요가 증가하고 있으며, 시장 점유율이 가장 높을 것으로 예상됩니다. 또한, 세포주 개발, 바이오리액터 기술, 바이오 공정 기술의 발전은 제품 품질 향상, 높은 수율, 효율적인 생산 공정으로 이어져 이 분야의 폭발적인 성장에 박차를 가하고 있습니다. 마찬가지로, 정확한 표적 치료의 필요성과 만성질환의 증가도 포유류 항체에 대한 수요를 촉진하고 있습니다.

시장은 최종 용도에 따라 학계 및 연구기관, 바이오 제약사, CMO 및 CDMO로 분류되며, CMO 및 CDMO 분야는 CDMO 및 CMO의 전문 분야인 복잡한 제조 기술로 인해 예측 기간 동안 우위를 유지할 것으로 예상됩니다. 이들 조직은 제조 공정을 아웃소싱하고자 하는 기업에게 간편하고 저렴한 솔루션을 제공하고, 기업은 개발 및 연구에 전념할 수 있습니다. 또한, 품질 기준과 규제 요건이 더욱 엄격해짐에 따라 제약기업은 이러한 요구사항을 충족할 수 있는 숙련도를 유지하는 신뢰할 수 있는 CMO 및 CDMO와 협력할 필요가 있습니다.

포유류 세포 발효 기술 시장 : 지역별 분석

북미는 포유류 세포 발효 기술 시장에서 가장 큰 점유율을 차지하고 있습니다. 시장 성장의 배경에는 고도로 발달한 의료 부문, 유리한 정부 규제, 주요 바이오 제약 기업의 강력한 존재감이 있습니다. 또한, 생물학적 제제 및 바이오시밀러에 대한 수요 증가와 만성질환의 유병률 증가가 이 지역의 시장 성장을 주도하고 있습니다.

아시아태평양은 저렴한 비용으로 숙련된 인력을 쉽게 구할 수 있고, 규제 환경이 양호하며, 다국적 기업의 투자가 증가하고 있기 때문에 빠르게 성장할 가능성이 높습니다.

포유류 세포 발효 기술 시장 : 경쟁 상황

포유류 세포 발효 시장은 세포배양 기술 발전에 의해 주도되고 있습니다. 포유류 세포 발효 기술에 대한 수요 증가는 다양한 용도로 활용되기 때문에 주요 기업들이 자본을 투자할 수 있는 다양한 시장 잠재력을 창출하고 있습니다. 이러한 업계 기업들은 주로 인수, 제휴, 파트너십, 합병을 포함한 여러 전략을 채택하여 세계적인 발자취를 쌓고 시장 경쟁을 유지하기 위해 노력하고 있습니다. 또한, 바이오 제조 인프라에 대한 지출 증가와 함께 바이오 공정 기술을 강화하기 위한 연구 개발이 진행되고 있는 것도 시장의 발전을 촉진하고 있습니다. 예를 들어, 2023년 1월, 불산제약은 자체 개발한 항 PD-1 단클론항체(mAb) 셀루플리맙의 상용화를 위해 미국에서 상하이 헨리우스 바이오텍(Shanghai Henrys Biotech)과 독점 라이선스 계약을 체결했습니다. 이는 미국에서의 불산제약 개발의 중요한 전환점이 될 것입니다.

목차

제1장 포유류 세포 발효 기술 시장 개요

  • 조사 범위
  • 시장 추정 기간

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 포유류 세포 발효 기술의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장 전망 동향

제4장 포유류 세포 발효 기술 시장 : 산업 분석

  • PEST 분석
  • Porter's Five Forces 분석
  • 시장 성장 전망 : 매핑
  • 규제 체제 분석

제5장 포유류 세포 발효 기술 시장 : 높아지는 지정학적 긴장의 영향

  • COVID-19 팬데믹의 영향
  • 러시아·우크라이나 전쟁의 영향
  • 중동 분쟁의 영향

제6장 포유류 세포 발효 기술 시장 상황

  • 포유류 세포 발효 기술 시장 점유율 분석(2024년)
  • 주요 제조업체별 내역 데이터
    • 기존 기업 분석
    • 신흥 기업 분석

제7장 포유류 세포 발효 기술 시장 : 종류별

  • 개요
    • 부문별 점유율 분석 : 종류별
    • 베이비 햄스터 신장(BHK) 세포 발효
    • 중국 햄스터 난소(CHO) 세포 발효
    • 인간 배아 신장(HEK) 세포 발효
    • 쥐 골수종 세포 발효
    • 기타

제8장 포유류 세포 발효 기술 시장 : 용도별

  • 개요
    • 부문별 점유율 분석 : 용도별
    • 효소
    • 호르몬
    • 단클론항체
    • 재조합 단백질
    • 백신
    • 기타

제9장 포유류 세포 발효 기술 시장 : 최종 용도별

  • 개요
    • 부문별 점유율 분석 : 최종 용도별
    • 학술연구기관
    • 바이오의약품 기업
    • CMO·CDMO

제10장 포유류 세포 발효 기술 시장 : 지역별

  • 소개
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인
    • 네덜란드
    • 스웨덴
    • 러시아
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 주요 제조업체
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주
    • 인도네시아
    • 태국
    • 필리핀
    • 기타
  • 라틴아메리카(LATAM)
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카(MEA)
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제11장 주요 벤더 분석 : 포유류 세포 발효 기술 업계

  • 경쟁 대시보드
    • 경쟁 벤치마크
    • 경쟁 포지셔닝
  • 기업 개요
    • AstraZeneca
    • Danaher
    • Thermo Fisher Scientific, Inc.
    • Regeneron Pharmaceuticals
    • Merck KGaA
    • Lonza
    • Gilead Sciences
    • F. Hoffmann-La Roche Ltd
    • Moderna, Inc
    • Bristol-Myers Squibb
    • Amgen
    • Sartorius AG
    • Others

제12장 AnalystView의 전방위적 분석

ksm 25.04.15

REPORT HIGHLIGHT

Mammalian cell fermentation technology Market size was valued at US$ 50,789.43 Million in 2024, expanding at a CAGR of 8.99% from 2025 to 2032.

Mammalian cells are widely used for producing therapeutic proteins like vaccines, monoclonal antibodies, and other biologics, along with various source materials like Human Embryonic Kidney (HEK) cells, Chinese Hamster Ovary (CHO) cells, and others. The mammalian cell fermentation technology industry will likely see significant growth in the forecasted years due to several factors, such as the rising demand for biosimilars and biologics, the increasing prevalence of chronic diseases, and advancements in mammalian cell culture techniques.

Mammalian Cell Fermentation Technology Market- Market Dynamics

Increasing demand for biologics and biosimilars to propel market growth

The mammalian cell fermentation technology industry is witnessing a significant rise due to the rising demand for biosimilars and biologics. These treatments are important in managing various conditions, including infectious diseases, cancer, and autoimmune conditions. Additionally, mammalian cell fermentation technology keeps expanding as pharmaceutical firms invest more in the creation of novel biologics. However, a vital factor restraining the widespread use of this technology is the high expenses associated with its manufacturing process. Furthermore, the rise in chronic diseases like cancer, diabetes, and heart disease resulted in a growth in the mammalian cell fermentation technology market. There is an ongoing demand for mammalian cell fermentation technologies as many diseases need long-term treatment, often with biologics. As a result, the market for mammalian cell fermentation technology is projected to grow over the coming years owing to the constant demand for biosimilars and biologics along with the rise in chronic illnesses.

Mammalian Cell Fermentation Technology Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.99% over the forecast period (2025-2032)

Based on type segmentation, Chinese hamster ovary (CHO) cell fermentation was predicted to show maximum market share in the year 2024

Based on application segmentation, monoclonal antibodies was the leading application in 2024

Based on end-use segmentation, CMOs & CDMOs was the leading end-use in 2024

On the basis of region, North America was the leading revenue generator in 2024

Mammalian Cell Fermentation Technology Market- Segmentation Analysis:

The global mammalian cell fermentation technology market is segmented on the basis of type, application, end-use, and region.

The market is divided into five categories based on type: baby hamster kidney (BHK) cell fermentation, chinese hamster ovary (CHO) cell fermentation, human embryonic kidney (HEK) Cell fermentation, murine myeloma cell fermentation, and others. The Chinese hamster ovary (CHO) cell fermentation sector is expected to dominate the market. CHO cells have prompted immense attention because of their ability to efficiently manufacture complex therapeutic proteins. Additionally, the rise in demand can be attributed to various factors such as the optimization of culture media and conditions, advancements in genetic engineering techniques for enhancing cell line development, and a robust regulatory environment.

The market is divided into six categories based on application: enzymes, hormones, monoclonal antibodies, recombinant proteins, vaccines, others. The monoclonal antibodies segment is likely to hold the highest market share as high adoption can be attributed to the crucial role that antibodies play in diagnostic and therapeutic applications, leading to growing demand for robust production methods. In addition, advancements in cell line development, bioreactor technologies, and bioprocessing techniques, leading to better product quality, higher yields, and efficient production processes, have fueled the segment's explosive expansion. Likewise, the need for precisely targeted therapies and the increasing prevalence of chronic diseases have also fueled the demand for mammalian antibodies.

The market is divided into three categories based on end-use: academic & research institutes, biopharmaceutical companies, and CMOs & CDMOs. The CMOs & CDMOs sector is likely to maintain its dominance during the forecast period due to the complex manufacturing techniques that CDMOs and CMOs specialize in. These organizations provide a simplified and affordable solution for businesses aiming to outsource their manufacturing processes, allowing them to concentrate on development and research. Moreover, quality standards and regulatory requirements are more stringent, thereby pharmaceutical businesses to collaborate with reputable CMOs and CDMOs that maintain the proficiency to comply with these demands.

Mammalian Cell Fermentation Technology Market- Geographical Insights

North America accounts for the largest share of the mammalian cell fermentation technology market. The market growth is attributed to the region's highly developed healthcare sector, favorable government regulations, and a strong presence of significant biopharmaceutical companies. Moreover, the rising demand for biologics and biosimilars and the rising incidence of chronic illnesses are attributed to driving the region's market growth.

The Asia Pacific region is likely to increase at a swift rate owing to the accessibility of trained staff at a reduced cost, the favorable regulatory environment, and rising investments by multinational corporations.

Mammalian Cell Fermentation Technology Market- Competitive Landscape:

The market for fermenting mammalian cells is being driven by technological advancements in cell culture. The rising demand for mammalian cell fermentation technology for numerous applications has created various market possibilities for major players to capitalize on. These industry players primarily adopt several strategies that involve acquisitions, collaborations, partnerships, and mergers to establish a global footprint and maintain market competition. Moreover, the market's progress is fostered by the ongoing research and development efforts to enhance bioprocessing methods, along with the rising spending on biomanufacturing infrastructure. For instance, in January 2023, Fosun Pharmahas signed an exclusive license agreement with Shanghai Henlius Biotech, Inc. in the United States (US) for the commercialization of Henlius independently developed anti-PD-1 monoclonal antibody (mAb) serplulimab. This marks a significant turning point for Fosun Pharma's development in the US.

Recent Developments:

In July 2023, Lonza launched the TheraPRO(R) CHO Media System, an innovative cell culture platform that streamlines procedures and optimizes productivity and protein quality when utilized with GS-CHO cell lines. The launch of this technology supports biotechnology and pharmaceutical companies that manufacture therapeutic proteins to enhance product quality while streamlining time-to-market.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • AstraZeneca
  • Danaher
  • Thermo Fisher Scientific, Inc.
  • Regeneron Pharmaceuticals
  • Merck KGaA
  • Lonza
  • Gilead Sciences
  • F. Hoffmann-La Roche Ltd
  • Moderna, Inc
  • Bristol-Myers Squibb
  • Amgen
  • Sartorius AG
  • Others

GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Baby Hamster Kidney (BHK) Cell Fermentation
  • Chinese Hamster Ovary (CHO) Cell Fermentation
  • Human Embryonic Kidney (HEK) Cell Fermentation
  • Murine Myeloma Cell Fermentation
  • Others

GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Enzymes
  • Hormones
  • Monoclonal Antibodies
  • Recombinant Proteins
  • Vaccines
  • Others

GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

  • Academic & Research Institutes
  • Biopharmaceutical Companies
  • CMOs & CDMOs

GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Mammalian Cell Fermentation Technology Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Mammalian Cell Fermentation Technology Market Snippet by Type
    • 2.1.2. Mammalian Cell Fermentation Technology Market Snippet by Application
    • 2.1.3. Mammalian Cell Fermentation Technology Market Snippet by End-use
    • 2.1.4. Mammalian Cell Fermentation Technology Market Snippet by Country
    • 2.1.5. Mammalian Cell Fermentation Technology Market Snippet by Region
  • 2.2. Competitive Insights

3. Mammalian Cell Fermentation Technology Key Market Trends

  • 3.1. Mammalian Cell Fermentation Technology Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Mammalian Cell Fermentation Technology Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Mammalian Cell Fermentation Technology Market Opportunities
  • 3.4. Mammalian Cell Fermentation Technology Market Future Trends

4. Mammalian Cell Fermentation Technology Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Mammalian Cell Fermentation Technology Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Mammalian Cell Fermentation Technology Market Landscape

  • 6.1. Mammalian Cell Fermentation Technology Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Mammalian Cell Fermentation Technology Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024&2032 (%)
    • 7.1.2. Baby Hamster Kidney (BHK) Cell Fermentation
    • 7.1.3. Chinese Hamster Ovary (CHO) Cell Fermentation
    • 7.1.4. Human Embryonic Kidney (HEK) Cell Fermentation
    • 7.1.5. Murine Myeloma Cell Fermentation
    • 7.1.6. Others

8. Mammalian Cell Fermentation Technology Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024&2032 (%)
    • 8.1.2. Enzymes
    • 8.1.3. Hormones
    • 8.1.4. Monoclonal Antibodies
    • 8.1.5. Recombinant Proteins
    • 8.1.6. Vaccines
    • 8.1.7. Others

9. Mammalian Cell Fermentation Technology Market - By End-use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-use, 2024&2032 (%)
    • 9.1.2. Academic & Research Institutes
    • 9.1.3. Biopharmaceutical Companies
    • 9.1.4. CMOs & CDMOs

10. Mammalian Cell Fermentation Technology Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024&2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Mammalian Cell Fermentation Technology Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Mammalian Cell Fermentation Technology Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Mammalian Cell Fermentation Technology Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Mammalian Cell Fermentation Technology Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Mammalian Cell Fermentation Technology Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Mammalian Cell Fermentation Technology Industry

  • 11.1. Competitive Benchmarking
    • 11.1.1. Competitive Dashboard
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. AstraZeneca
    • 11.2.2. Danaher
    • 11.2.3. Thermo Fisher Scientific, Inc.
    • 11.2.4. Regeneron Pharmaceuticals
    • 11.2.5. Merck KGaA
    • 11.2.6. Lonza
    • 11.2.7. Gilead Sciences
    • 11.2.8. F. Hoffmann-La Roche Ltd
    • 11.2.9. Moderna, Inc
    • 11.2.10. Bristol-Myers Squibb
    • 11.2.11. Amgen
    • 11.2.12. Sartorius AG
    • 11.2.13. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제